Your browser doesn't support javascript.
loading
Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External Validation.
Mungroop, Timothy H; van Rijssen, L Bengt; van Klaveren, David; Smits, F Jasmijn; van Woerden, Victor; Linnemann, Ralph J; de Pastena, Matteo; Klompmaker, Sjors; Marchegiani, Giovanni; Ecker, Brett L; van Dieren, Susan; Bonsing, Bert; Busch, Olivier R; van Dam, Ronald M; Erdmann, Joris; van Eijck, Casper H; Gerhards, Michael F; van Goor, Harry; van der Harst, Erwin; de Hingh, Ignace H; de Jong, Koert P; Kazemier, Geert; Luyer, Misha; Shamali, Awad; Barbaro, Salvatore; Armstrong, Thomas; Takhar, Arjun; Hamady, Zaed; Klaase, Joost; Lips, Daan J; Molenaar, I Quintus; Nieuwenhuijs, Vincent B; Rupert, Coen; van Santvoort, Hjalmar C; Scheepers, Joris J; van der Schelling, George P; Bassi, Claudio; Vollmer, Charles M; Steyerberg, Ewout W; Abu Hilal, Mohammed; Groot Koerkamp, Bas; Besselink, Marc G.
Afiliação
  • Mungroop TH; Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.
  • van Rijssen LB; Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.
  • van Klaveren D; Department of Public Health, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Smits FJ; Department of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.
  • van Woerden V; Department of Surgery, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Linnemann RJ; Department of Surgery, Isala Clinics, Zwolle, the Netherlands.
  • de Pastena M; Department of Surgery, Pancreas Institute of the University of Verona Hospital Trust, Verona, Italy.
  • Klompmaker S; Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.
  • Marchegiani G; Department of Surgery, Pancreas Institute of the University of Verona Hospital Trust, Verona, Italy.
  • Ecker BL; Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA.
  • van Dieren S; Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.
  • Bonsing B; Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA.
  • Busch OR; Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.
  • van Dam RM; Department of Surgery, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Erdmann J; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • van Eijck CH; Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Gerhards MF; Department of Surgery, OLVG Oost, Amsterdam, the Netherlands.
  • van Goor H; Department of Surgery, Radboud University Medical Center, the Netherlands.
  • van der Harst E; Department of Surgery, Maasstad Hospital, Rotterdam, the Netherlands.
  • de Hingh IH; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.
  • de Jong KP; Department of Surgery, University Medical Center Groningen, Groningen, the Netherlands.
  • Kazemier G; Department of Surgery, VU University Medical Center, Amsterdam, the Netherlands.
  • Luyer M; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.
  • Shamali A; Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Barbaro S; Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Armstrong T; Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Takhar A; Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Hamady Z; Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Klaase J; Department of Surgery, Medisch Spectrum Twente, Enschede, the Netherlands.
  • Lips DJ; Department of Surgery, Jeroen Bosch Hospital, 's Hertogenbosch, the Netherlands.
  • Molenaar IQ; Department of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Nieuwenhuijs VB; Department of Surgery, Isala Clinics, Zwolle, the Netherlands.
  • Rupert C; Department of Surgery, Tjongerschans Hospital, Heerenveen, the Netherlands.
  • van Santvoort HC; Department of Surgery, St. Antonius Hospital, Nieuwegein, the Netherlands.
  • Scheepers JJ; Department of Surgery, Reinier de Graaf Gasthuis, Delft, the Netherlands.
  • van der Schelling GP; Department of Surgery, Amphia Hospital, Breda, the Netherlands.
  • Bassi C; Department of Surgery, Pancreas Institute of the University of Verona Hospital Trust, Verona, Italy.
  • Vollmer CM; Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA.
  • Steyerberg EW; Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Abu Hilal M; Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Groot Koerkamp B; Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Besselink MG; Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.
Ann Surg ; 269(5): 937-943, 2019 05.
Article em En | MEDLINE | ID: mdl-29240007
ABSTRACT

OBJECTIVE:

The aim of this study was to develop an alternative fistula risk score (a-FRS) for postoperative pancreatic fistula (POPF) after pancreatoduodenectomy, without blood loss as a predictor.

BACKGROUND:

Blood loss, one of the predictors of the original-FRS, was not a significant factor during 2 recent external validations.

METHODS:

The a-FRS was developed in 2 databases the Dutch Pancreatic Cancer Audit (18 centers) and the University Hospital Southampton NHS. Primary outcome was grade B/C POPF according to the 2005 International Study Group on Pancreatic Surgery (ISGPS) definition. The score was externally validated in 2 independent databases (University Hospital of Verona and University Hospital of Pennsylvania), using both 2005 and 2016 ISGPS definitions. The a-FRS was also compared with the original-FRS.

RESULTS:

For model design, 1924 patients were included of whom 12% developed POPF. Three predictors were strongly associated with POPF soft pancreatic texture [odds ratio (OR) 2.58, 95% confidence interval (95% CI) 1.80-3.69], small pancreatic duct diameter (per mm increase, OR 0.68, 95% CI 0.61-0.76), and high body mass index (BMI) (per kg/m increase, OR 1.07, 95% CI 1.04-1.11). Discrimination was adequate with an area under curve (AUC) of 0.75 (95% CI 0.71-0.78) after internal validation, and 0.78 (0.74-0.82) after external validation. The predictive capacity of a-FRS was comparable with the original-FRS, both for the 2005 definition (AUC 0.78 vs 0.75, P = 0.03), and 2016 definition (AUC 0.72 vs 0.70, P = 0.05).

CONCLUSION:

The a-FRS predicts POPF after pancreatoduodenectomy based on 3 easily available variables (pancreatic texture, duct diameter, BMI) without blood loss and pathology, and was successfully validated for both the 2005 and 2016 POPF definition. The online calculator is available at www.pancreascalculator.com.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Fístula Pancreática / Pancreaticoduodenectomia / Medição de Risco Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Fístula Pancreática / Pancreaticoduodenectomia / Medição de Risco Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article